(Q53233479)

12 May 2018

title

Increased lipoprotein oxidation in Alzheimer's disease. (English)

1 reference

12 May 2018

1 reference

Schippling S

1

1 reference

12 May 2018

Kontush A

2

1 reference

12 May 2018

Arlt S

3

1 reference

12 May 2018

Buhmann C

4

1 reference

12 May 2018

Stürenburg HJ

5

1 reference

12 May 2018

Mann U

6

1 reference

12 May 2018

Müller-Thomsen T

7

1 reference

12 May 2018

Beisiegel U

8

1 reference

12 May 2018

publication date

1 February 2000

1 reference

12 May 2018

Free Radical Biology and Medicine

published in

1 reference

12 May 2018

volume

28

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

351-360

1 reference

12 May 2018

Amyloid, the presenilins and Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Oxidative stress hypothesis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Reactive oxygen species and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Vitamin Homeostasis in the Central Nervous System

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Vitamin E (tocopherols) in human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Early AGEing and Alzheimer's.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Cerebrospinal fluid trace element content in dementia: clinical, radiologic, and pathologic correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Vitamin E protects nerve cells from amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Oxidative mechanisms in beta-amyloid cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Time-course of oxidation of lipids in human cerebrospinal fluid in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Continuous monitoring of in vitro oxidation of human low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Analysis of lipoprotein diene formation in human serum exposed to copper

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Measurement of oxidizability of blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Alpha-tocopherol as a reductant for Cu(II) in human lipoproteins. Triggering role in the initiation of lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

High-performance liquid chromatography-coulometric electrochemical detection of ubiquinol 10, ubiquinone 10, carotenoids, and tocopherols in neonatal plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Vitamin C, dehydroascorbate, and uric acid in tissues and serum: high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

APOE is a major susceptibility gene for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Iron released from transferrin at acidic pH can catalyse the oxidation of low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Ceruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Redox metals and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Reduction of copper, but not iron, by human low density lipoprotein (LDL). Implications for metal ion-dependent oxidative modification of LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Antioxidant activity of vitamin C in iron-overloaded human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900247-6

7 January 2021

10.1016/S0891-5849(99)00247-6

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018